{"entity":{"type":"insider","cik":"0001612627","url":"/insider/0001612627","json_url":"/insider/0001612627.json","name":"Vuori Kristiina MD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2016-12-13","last":"2024-10-07","span_basis":"filed_date"},"name_variants":[{"name":"Vuori Kristiina MD","source":"filing","n_filings":4,"first_seen":"2016-12-13","last_seen":"2024-10-07"}],"transactions":[{"id":2623333,"accession":"0002007919-24-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002007919-24-000051","line_url":"/filing/0002007919-24-000051#line-1","is_derivative":false,"issuer_cik":"0001612627","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001612627","owner_cik":"0001612627","owner_name":"Vuori Kristiina MD","owner_display_name":"Vuori Kristiina MD","owner_url":"/insider/0001612627","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6667.0,"shares_display":"6,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":100005.0,"total_display":"100,005.00","total_whole":"100,005","shares_owned_after":20443.0,"shares_owned_after_display":"20,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-07","scope":"insider"},{"id":3274395,"accession":"0002007919-24-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002007919-24-000047","line_url":"/filing/0002007919-24-000047#line-2","is_derivative":false,"issuer_cik":"0001612627","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001612627","owner_cik":"0001612627","owner_name":"Vuori Kristiina MD","owner_display_name":"Vuori Kristiina MD","owner_url":"/insider/0001612627","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6457.0,"shares_display":"6,457","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":97306.99,"total_display":"97,306.99","total_whole":"97,307","shares_owned_after":13776.0,"shares_owned_after_display":"13,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-12","scope":"insider"},{"id":3274391,"accession":"0002007919-24-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002007919-24-000047","line_url":"/filing/0002007919-24-000047#line-1","is_derivative":false,"issuer_cik":"0001612627","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001612627","owner_cik":"0001612627","owner_name":"Vuori Kristiina MD","owner_display_name":"Vuori Kristiina MD","owner_url":"/insider/0001612627","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":179.0,"shares_display":"179","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":2685.0,"total_display":"2,685.00","total_whole":"2,685","shares_owned_after":7319.0,"shares_owned_after_display":"7,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2406866,"accession":"0001739614-24-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-24-000035","line_url":"/filing/0001739614-24-000035#line-1","is_derivative":false,"issuer_cik":"0001612627","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001612627","owner_cik":"0001612627","owner_name":"Vuori Kristiina MD","owner_display_name":"Vuori Kristiina MD","owner_url":"/insider/0001612627","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7140.0,"shares_display":"7,140","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":99960.0,"total_display":"99,960.00","total_whole":"99,960","shares_owned_after":7140.0,"shares_owned_after_display":"7,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-29","filed_date":"2024-09-03","scope":"insider"},{"id":2821441,"accession":"0000947871-16-001767","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-16-001767","line_url":"/filing/0000947871-16-001767","is_derivative":false,"issuer_cik":"0001326583","issuer_name":"WebMD Health Corp.","issuer_ticker":"WBMD","issuer_name_source":null,"issuer_url":"/issuer/0001326583","owner_cik":"0001612627","owner_name":"Vuori Kristiina MD","owner_display_name":"Vuori Kristiina MD","owner_url":"/insider/0001612627","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1561.0,"shares_display":"1,561","price_per_share":53.012562459961565,"price_display":"53.01","price_state":"stated","total_value":82752.61,"total_display":"82,752.61","total_whole":"82,753","shares_owned_after":2190.0,"shares_owned_after_display":"2,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-12","filed_date":"2016-12-13","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002007919","name":"Inhibrx Biosciences, Inc.","url":"/issuer/0002007919","role":"Director","n_filings":3,"first_seen":"2024-09-03","last_seen":"2024-10-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001326583","name":"WebMD Health Corp.","url":"/issuer/0001326583","role":"Director","n_filings":1,"first_seen":"2016-12-13","last_seen":"2016-12-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612627","retrieved_at":"2026-08-27T13:33:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}